Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q0V8T9

Entry ID Method Resolution Chain Position Source
AF-Q0V8T9-F1 Predicted AlphaFoldDB

55 variants for Q0V8T9

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388493535 3 S>P No EVA
rs3390493193 83 Q>* No EVA
rs3390474904 84 N>H No EVA
rs3390497813 85 R>* No EVA
rs3390497327 85 R>S No EVA
rs3390526961 85 R>T No EVA
rs3390430753 88 I>F No EVA
rs3390460673 89 T>A No EVA
rs3390474913 111 S>R No EVA
rs3388492733 188 S>* No EVA
rs3388492443 222 E>D No EVA
rs3388494040 227 D>Y No EVA
rs3388493584 254 T>S No EVA
rs3412836058 260 L>Q No EVA
rs3388492196 262 S>I No EVA
rs3390513722 264 L>Q No EVA
rs3388493310 298 T>R No EVA
rs3388493583 338 V>L No EVA
rs3388495846 370 F>Y No EVA
rs3388490904 447 D>G No EVA
rs3388494056 480 I>M No EVA
rs3388492749 486 K>N No EVA
rs3388492658 575 T>S No EVA
rs3388492605 610 G>D No EVA
rs261413938 658 G>D No EVA
rs3388493568 676 Q>* No EVA
rs223989601 692 D>G No EVA
rs3388492622 700 I>N No EVA
rs256306668 713 A>S No EVA
rs3388493272 720 C>Y No EVA
rs258069736 741 I>T No EVA
rs240586379 748 T>S No EVA
rs3388493262 808 H>L No EVA
rs258096442 867 Y>H No EVA
rs243719393 871 D>N No EVA
rs3390511060 874 W>C No EVA
rs3388495708 921 S>L No EVA
rs3388490909 1000 A>G No EVA
rs3388493868 1000 A>S No EVA
rs30647218 1001 L>I No EVA
rs3388490915 1029 I>F No EVA
rs30647215 1033 L>S No EVA
rs50589008 1047 T>I No EVA
rs3388492578 1086 H>L No EVA
rs3412795737 1104 K>N No EVA
rs3388492457 1106 S>C No EVA
rs261713760 1110 P>T No EVA
rs212185325 1124 S>N No EVA
rs30637657 1127 P>S No EVA
rs3388495670 1153 A>V No EVA
rs3388494073 1185 A>V No EVA
rs3388495809 1251 F>C No EVA
rs3388494085 1259 R>L No EVA
rs3388494032 1260 F>I No EVA
rs233078775 1297 E>D No EVA

No associated diseases with Q0V8T9

3 regional properties for Q0V8T9

Type Name Position InterPro Accession
domain Basic-leucine zipper domain 71 - 135 IPR004827
domain Vertebrate interleukin-3 regulated transcription factor 130 - 461 IPR010533
domain Nuclear factor interleukin-3-regulated protein-like, bZIP domain 72 - 131 IPR047106

Functions

Description
EC Number
Subcellular Localization
  • Membrane ; Single-pass type I membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
neuron projection A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

1 GO annotations of molecular function

Name Definition
aspartic-type endopeptidase activity Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile.

2 GO annotations of biological process

Name Definition
cell adhesion The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
proteolysis The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
M9PE65 axo Axotactin Drosophila melanogaster (Fruit fly) SS
P78357 CNTNAP1 Contactin-associated protein 1 Homo sapiens (Human) PR
10 20 30 40 50 60
MDSVPRLNSV LTLVLSGLWH LGLTATNYNC DDPLSNFLSL KAFSSSSDIT GSSSSAQLNW
70 80 90 100 110 120
RMGTGGWSPA DSNAQQWLQI DLQNRVEITA VATQGRYGSS DWVTSYRLMF SDTGHNWQPY
130 140 150 160 170 180
NQEDSIWTFV GNMNSDSVVH HKLLHSVRAR FVRFVPLEWN PNGKIGMRVE AYGCSYRSDV
190 200 210 220 230 240
ADFDGRSSLL YRFNQKTMST LKDVISLKFK SMQGDGVLFH GEGQRGDHIT LELQKGRLAL
250 260 270 280 290 300
YLNLDDSKAR LSSTVPLVIL GSLLDDQHWH SVLLERVGKQ ANFTVDMNTQ HFRTKGDTDS
310 320 330 340 350 360
LDIDYELSFG GIPVPSKPGT FLKKNFHGCI ENLYYNGVNI IDLAKRRKHQ IYSGNVTFSC
370 380 390 400 410 420
SEPQIVPITF INSRSSYLML PGTPQIDGLS VSFQFRTWNE DGLLLSTELS EGSGTLLLIL
430 440 450 460 470 480
EGGTLRLLIK KVARHGTEIL TGSGLNDGLW HSVSINARRN RVTLTLDNDA ASPAPDTSRI
490 500 510 520 530 540
QIYSGKSYYF GGCPDNLTDS QCLNPIKAFQ GCMRLIFIDN QPKDLISVQQ GSLGSFSDLH
550 560 570 580 590 600
IDLCSIKDRC LPNYCEHGGH CDQTWTTFYC NCSGTGYTGA TCHDSIYEQS CEVYRHRGHT
610 620 630 640 650 660
AGFFYVDSDG SGPLGPLQVY CNITEDKIWM TVQHNNTELT RVQGSSPENP YSMTLNYGGS
670 680 690 700 710 720
MEQLEALIDG SEYCEQEVIY HCRRSRLLNT PDGAPFTWWI GRSTERHPYW GGAVPGVQQC
730 740 750 760 770 780
GCGLEESCLD SRHFCNCDAD IDEWANDTGL FSFKDHLPVT QIIIMDTNRT NSEAAWRIGP
790 800 810 820 830 840
LRCYGDRHFW NAVSFSTEAS YLHFPTFHTE FSADISFFFK TTALSGVFLE NLGIKDFFRL
850 860 870 880 890 900
EMSSPSEVTF AIDVGNGPIE LLVQSPYPLN DNQWHYIRAE TNLKETSLQV DNLPQSMREA
910 920 930 940 950 960
SEGGHFRLQL NSQLFVGGTS SRQKGFLGCI RSLLLNGHKV DLEERAKVTS GVRPGCPGHC
970 980 990 1000 1010 1020
SSYGSNCHNG GKCVEKHTGY SCDCTNSPYE GPFCRKEISA LFDSGTSVTY MFQEPYPVTK
1030 1040 1050 1060 1070 1080
NTSLSSSAIY TDLAPFKETI MLSFMTTQAP TLLLYLNFSS QNFLAILLSR NGSLQVRYRL
1090 1100 1110 1120 1130 1140
SKDESHVFNM DTENLANRRV HQVKISRDGP ELSIQMDQQL FSYSFSPEVE FRTLRSLVLG
1150 1160 1170 1180 1190 1200
KVTETLDLDP EVARANTLGF VGCLSSVQYN HIAPLKAALR HASIAPVTVQ KTLTESSCGS
1210 1220 1230 1240 1250 1260
MVDSDVNAVT TVHSLSDSFG KTDDHEPLQN AVRSDSAVIG GVIAVVTFIT FCVIGIMTRF
1270 1280 1290 1300
LYQHKQSHRT NQMKKEYPEN LDNSFRNEID LQNTATECKR EYFI